BioMarin Pharmaceutical

NASDAQ: BMRN
$83.92
+$0.77 (+0.9%)
Closing price June 29, 2022
These five stock picks from the Goldman Sachs Conviction List offer ideas for aggressive investors with longer time horizons and a higher risk tolerance to consider now. Two blue-chip sector leaders...
Tuesday's top analyst upgrades and downgrades included Atlassian, Autodesk, BioMarin Pharmaceutical, Darden Restaurants, DraftKings, eBay, Fortinet, LyondellBasell Industries, Riot Blockchain and WEC...
Monday's additional top analyst upgrades and downgrades included BioMarin Pharmaceutical, Micron Technology, Quanta Services, Sangamo Therapeutics, Silvergate Capital, T. Rowe Price and Zendesk.
Thursday's top analyst upgrades and downgrades included Analog Devices, Aptiv, CF Industries, Ford, Mosaic, Park Hotels & Resorts, Patterson-UTI Energy, Pinterest, Plug Power, Salesforce, Snap,...
These five Goldman Sachs Conviction List stock picks are ideas that aggressive investors with longer time horizons and a higher risk tolerance may want to consider, given the host of woes that...
Wednesday's top analyst upgrades and downgrades included Academy Sports & Outdoors, Arista Networks, Colgate-Palmolive, Expedia, Global Payments, Huntsman, InMode, ON Semiconductor and Zoominfo...
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal,...
Friday's top analyst upgrades and downgrades included Amgen, Amphenol, Harley-Davidson, Hertz Global, Las Vegas Sands, Masco, Meta Platforms, NXP Semiconductors, Oshkosh, PayPal, Pinterest,...
Monday’s additional top analyst upgrades and downgrades included Agilent Technologies, Barrick Gold, Deere, Kellogg, Marathon Oil, Newmont, Penn National Gaming, Spotify Technology and Verizon...
Growth investors who are more aggressive and looking for Wall Street’s best ideas amid the current market uncertainties may want to consider these five Goldman Sachs Conviction List picks. If their...
Monday afternoon's analyst upgrades and downgrades included Activision Blizzard, BioMarin, eBay and Teladoc.
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Thursday’s top analyst upgrades and downgrades included Baker Hughes, BioMarin Pharmaceutical, Cisco Systems, Haliburton, Macy’s, Schlumberger and Sherwin-Williams.
Friday's top analyst upgrades and downgrades included ADS, BioMarin Pharmaceutical, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties and U.S. Steel.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.